Addison Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$147K Sell
2,123
-543
-20% -$37.5K 0.04% 257
2025
Q1
$185K Buy
2,666
+383
+17% +$26.6K 0.05% 219
2024
Q4
$196K Sell
2,283
-424
-16% -$36.5K 0.05% 208
2024
Q3
$322K Sell
2,707
-43
-2% -$5.12K 0.09% 154
2024
Q2
$393K Buy
2,750
+332
+14% +$47.4K 0.13% 122
2024
Q1
$310K Buy
2,418
+87
+4% +$11.2K 0.11% 139
2023
Q4
$241K Buy
2,331
+255
+12% +$26.4K 0.09% 151
2023
Q3
$189K Sell
2,076
-650
-24% -$59.1K 0.09% 163
2023
Q2
$221K Buy
2,726
+56
+2% +$4.53K 0.11% 141
2023
Q1
$212K Sell
2,670
-44
-2% -$3.5K 0.12% 135
2022
Q4
$184K Sell
2,714
-814
-23% -$55.1K 0.11% 136
2022
Q3
$176K Buy
3,528
+36
+1% +$1.8K 0.11% 129
2022
Q2
$195K Sell
3,492
-388
-10% -$21.7K 0.12% 127
2022
Q1
$215K Buy
3,880
+1,316
+51% +$72.9K 0.12% 126
2021
Q4
$144K Buy
2,564
+2,544
+12,720% +$143K 0.09% 150
2021
Q3
$1K Buy
+20
New +$1K ﹤0.01% 420